C3 and Alzheimer disease: We evaluated cerebrospinal fluid (CSF) measurements of the immune protein Complement 3 (C3) as well as amyloid β1-42 (amyloid) and ptau181p (ptau), which are sensitive in vivo markers of clinical diagnosis, decline, and pathology in AD [8, 9, 24].